Pathological confirmation of primary lung cancer following breast cancer

Lung Cancer

Volumn 69, Issue 1, 2010, Pages 40-45

  Tennis, M ^a   Singh, B ^c   Hjerpe, A ^b   Prochazka, M ^b   Czene, K ^b   Hall, P ^b   Shields, P G ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast neoplasms; Lung neoplasms; Neoplasms; Second primary

Indexed keywords

ESTROGEN RECEPTOR ALPHA; THYROID TRANSCRIPTION FACTOR 1; NUCLEAR PROTEIN; THYROID NUCLEAR FACTOR 1; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG METASTASIS; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SECOND CANCER; SWEDEN; ADENOCARCINOMA; ALGORITHM; BREAST NEOPLASMS; CLASSIFICATION; IMMUNOLOGY; LUNG NEOPLASMS; METABOLISM; METASTASIS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; REGISTER;

ADENOCARCINOMA; AGED; ALGORITHMS; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, SECOND PRIMARY; NUCLEAR PROTEINS; PROGNOSIS; REGISTRIES; TRANSCRIPTION FACTORS;

EID: 77953361644     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.08.018     Document Type: Article

References (38)

1. Wilkins K.L., Woodgate R.L. Preventing second cancers in cancer survivors. Oncol Nurs Forum 2008, 35:E12-22.
2. Desandes E., Berger C., Tron I., Demeocq F., Bellec S., Blouin P., et al. Childhood cancer survival in France, 1990-1999. Eur J Cancer 2008, 44:205-215.
3. Zhou C.X., Gao Y. Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis. Oncol Rep 2007, 17:73-79.
4. Matesich S.M., Shapiro C.L. Second cancers after breast cancer treatment. Semin Oncol 2003, 30:740-748.
5. Dawood S., Broglio K., Esteva F.J., Ibrahim N.K., Kau S.W., Islam R., Aldape K.D., Yu T.K., Hortobagyi G.N., Gonzalez-Angulo A.M. Defining prognosis for women with breast cancer and CNS metastases by HER2 status. Ann Oncol 2008.
6. Kirova Y.M., Gambotti L., De Rycke Y., Vilcoq J.R., Asselain B., Fourquet A. Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. Int J Radiat Oncol Biol Phys 2007, 68:359-363.
7. Hemminki K., Zhang H., Sundquist J., Lorenzo Bermejo J. Modification of risk for subsequent cancer after female breast cancer by a family history of breast cancer. Breast Cancer Res Treat 2007.
8. Park S.M., Lim M.K., Jung K.W., Shin S.A., Yoo K.Y., Yun Y.H., et al. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study. J Clin Oncol 2007, 25:4835-4843.
9. Soliman H., Agresta S.V. Current issues in adolescent and young adult cancer survivorship. Cancer Control 2008, 15:55-62.
10. Evans H.S., Lewis C.M., Robinson D., Bell C.M., Moller H., Hodgson S.V. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer 2001, 84:435-440.
11. Levi F., Te V.C., Randimbison L., La Vecchia C. Cancer risk in women with previous breast cancer. Ann Oncol 2003, 14:71-73.
12. Volk N., Pompe-Kirn V. Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control 1997, 8:764-770.
13. Soerjomataram I., Louwman W.J., de Vries E., Lemmens V.E., Klokman W.J., Coebergh J.W. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat 2005, 93:91-95.
14. Mellemkjaer L., Friis S., Olsen J.H., Scelo G., Hemminki K., Tracey E., et al. Risk of second cancer among women with breast cancer. Int J Cancer 2006, 118:2285-2292.
15. Tanaka H., Tsukuma H., Koyama H., Kinoshita Y., Kinoshita N., Oshima A. Second primary cancers following breast cancer in the Japanese female population. Jpn J Cancer Res 2001, 92:1-8.
16. Prochazka M., Granath F., Ekbom A., Shields P.G., Hall P. Lung cancer risks in women with previous breast cancer. Eur J Cancer 2002, 38:1520-1525.
17. Kaufman E.L., Jacobson J.S., Hershman D.L., Desai M., Neugut A.I. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol 2008, 26:392-398.
18. Prochazka M., Hall P., Gagliardi G., Granath F., Nilsson B.N., Shields P.G., et al. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. J Clin Oncol 2005, 23:7467-7474.
19. Neugut A.I., Murray T., Santos J., Amols H., Hayes M.K., Flannery J.T., et al. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer 1994, 73:1615-1620.
20. Inskip P.D., Stovall M., Flannery J.T. Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1994, 86:983-988.
21. Inskip P.D. Second cancers following radiotherapy. Multiple Primary Cancers 1999, Lippincott Williams & Wilkins, Philadelphia, pp. 91-135. A.I.M. Neugut (Ed.).
22. Deutsch M., Land S.R., Begovic M., Wieand H.S., Wolmark N., Fisher B. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer 2003, 98:1362-1368.
23. Dennis J.L., Hvidsten T.R., Wit E.C., Komorowski J., Bell A.K., Downie I., et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res 2005, 11:3766-3772.
24. Moldvay J., Jackel M., Bogos K., Soltesz I., Agocs L., Kovacs G., et al. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res 2004, 10:85-88.
25. Chang Y.L., Lee Y.C., Liao W.Y., Wu C.T. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer 2004, 44:149-157.
26. Zamecnik J., Kodet R. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch 2002, 440:353-361.
27. Jan I.S., Chung P.F., Weng M.H., Huang M.S., Lee Y.T., Kuo S.H. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique. J Formos Med Assoc 2006, 105:695-700.
28. Su Y.C., Hsu Y.C., Chai C.Y. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Kaohsiung J Med Sci 2006, 22:14-19.
29. Kayser K., Biechele U., Kayser G., Dienemann H., Andre S., Bovin N.V., et al. Pulmonary metastases of breast carcinomas: ligandohistochemical, nuclear, and structural analysis of primary and metastatic tumors with emphasis on period of occurrence of metastases and survival. J Surg Oncol 1998, 69:137-146.
30. Umekita Y., Sagara Y., Yoshida H. Estrogen receptor mutations and changes in estrogen receptor and progesterone receptor protein expression in metastatic or recurrent breast cancer. Jpn J Cancer Res 1998, 89:27-32.
31. Lower E.E., Glass E.L., Bradley D.A., Blau R., Heffelfinger S. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Breast Cancer Res Treat 2005, 90:65-70.
32. Koda M., Sulkowski S., Kanczuga-Koda L., Surmacz E., Sulkowska M. Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer. Oncol Rep 2004, 11:753-759.
33. Allred D.C., Harvey J.M., Berardo M., Clark G.M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998, 11:155-168.
34. Brenner D.J., Hall E.J., Curtis R.E., Ron E. Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum. Gastroenterology 2005, 129:773-774. author reply 774-775.
35. Bassal M., Mertens A.C., Taylor L., Neglia J.P., Greffe B.S., Hammond S., et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2006, 24:476-483.
36. Tucker M.A., Murray N., Shaw E.G., Ettinger D.S., Mabry M., Huber M.H., et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst 1997, 89:1782-1788.
37. Chang E.Y., Johnson W., Karamlou K., Khaki A., Komanapalli C., Walts D., et al. The evaluation and treatment implications of isolated pulmonary nodules in patients with a recent history of breast cancer. Am J Surg 2006, 191:641-645.
38. Ford M.B., Sigurdson A.J., Petrulis E.S., Ng C.S., Kemp B., Cooksley C., et al. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer 2003, 98:1457-1464.